Ureteral obstruction (UO) is one of the most common problems confronting th
e urologist, Although large amounts of animal and clinical research have be
en done, the pathophysiologic mechanisms accompanying UO are not fully eluc
idated. Most of our knowledge on UO has been derived from experimental stud
ies in a variety of animal models. Both antenatal and postnatal UO models h
ave been developed mainly by ligation of the ureter or by burying the urete
r into the psoas muscle. Most experimental studies have focused on short-te
rm complete ureteral obstruction. The long-term effects of partial ureteral
obstruction have been less intensively studied. It is now clear that obstr
uctive nephropathy is not a simple result of mechanical impairment to urine
flow but a complex syndrome resulting in alterations of both glomerular he
modynamics and tubular function caused by the interaction of a variety of v
asoactive factors and cytokines that are activated in response to UO. Leuko
cyte infiltration appears to play an important role in obstructive nephropa
thy suggesting that UO also has an immunological component. Growth factors
such as platelet-derived growth factor, transforming growth factor-beta, ep
idermal growth factor and insulin-like growth factor I may all play a role
in the development and progression of fibrotic and sclerotic changes in the
obstructed kidney. At present, the selection of patients with congenital h
ydronephrosis for operative treatment is controversial. Studies in animals
and patients have shown that partial unilateral UO does not always cause a
loss of renal function or progression in urinary tract dilation during long
-term follow-up. The implications of UO continue to raise many questions an
d further work is necessary to achieve a better understanding of the pathog
enesis in obstructive nephropathy.